Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews.

نویسندگان

  • Sarah Louise Klingenberg
  • Dimitrinka Nikolova
  • Nicholas Alexakis
  • Bodil Als-Nielsen
  • Agostino Colli
  • Dario Conte
  • Gennaro D'Amico
  • Brian Davidson
  • Abe Fingerhut
  • Mirella Fraquelli
  • Lise Lotte Gluud
  • Kurinchi Gurusamy
  • Frederik Keus
  • Saboor Khan
  • Ronald Koretz
  • Cornelis van Laarhoven
  • Jianping Liu
  • Robert Myers
  • Luigi Pagliaro
  • Rosa Simonetti
  • Robert Sutton
  • Kristian Thorlund
  • Christian Gluud
چکیده

BACKGROUND AND AIMS The Cochrane Hepato-Biliary Group (CHBG) is one of the 52 collaborative review groups within The Cochrane Collaboration. The activities of the CHBG focus on collecting hepato-biliary randomized clinical trials (RCT) and controlled clinical trials (CCT), and including them in systematic reviews with meta-analyses of the trials. In this overview, we present the growth of The CHBG Controlled Trials Register, as well as the systematic reviews that have been produced since March 1996. RESULTS The CHBG register includes almost 11,000 RCT and 700 CCT publications. The earliest RCT in the register were published in 1955, and the earliest CCT in 1945. From 1945 to 1980, there were less than 100 publications each year. From 1981 to 1997, their number increased from over 100 to 600 a year. After 1997, the number of publications seems to have been decreasing. The CHBG has published 199 protocols for systematic reviews and 107 systematic reviews through to August 2009 in which 21% of the RCT and CCT were included. The CHBG reviews have been cited approximately 1200 times. CONCLUSIONS A large amount of work has been carried out since 1996. However, there is still much to do, as the CHBG register contains a great number of RCT and CCT on topics that have not yet been systematically reviewed.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Cochrane hepato-biliary group as a resource example of evidence-based medicine for all.

PERSPECTIVA INTRODUCTION The Cochrane Hepato-Biliary Group (the CHBG) is a non-profit and not-for-profit independent, international, specialty research group within The Cochrane Collaboration (http://www.cochrane.org). Since its formation in 1996, The CHBG has established itself as a reliable source of evidence-based systematic reviews of interventions within the area of hepato-biliary diseases...

متن کامل

Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography.

BACKGROUND The use of prophylactic antibiotics before endoscopic retrograde cholangiopancreatography (ERCP) is recommended by all major international gastroenterological societies, especially in the presence of an obstructed biliary system. Their use is intended to decrease or eliminate the incidence of complications following the procedure, namely cholangitis, cholecystitis, septicaemia, and p...

متن کامل

D-penicillamine for primary biliary cirrhosis.

BACKGROUND D-penicillamine is used for patients with primary biliary cirrhosis due to its hepatic copper decreasing and immunomodulatory potentials. The results from randomised clinical trials have been inconsistent. OBJECTIVES To systematically review the beneficial and harmful effects of D-penicillamine for patients with primary biliary cirrhosis. SEARCH STRATEGY We identified trials thro...

متن کامل

Cholecystectomy deferral in patients with endoscopic sphincterotomy.

BACKGROUND Cholecystectomy is not required in up to 64% of patients who adopt a wait-and-see policy after endoscopic clearance of common bile duct stones. Although reports of retrospective cohort series have shown a higher mortality among patients who defer cholecystectomy, it is not known if this is due to the patients' premorbid health status or due to the deferral of cholecystectomy. Randomi...

متن کامل

Hormone replacement for osteoporosis in women with primary biliary cirrhosis.

BACKGROUND Women with primary biliary cirrhosis often suffer from postmenopausal osteoporosis due to their age, or osteoporosis secondary to their liver disease, or treatments provided for their liver disease. Hormone replacement increases bone mineral density and reduces fractures in postmenopausal women. On the other hand, hormone replacement increases the risk of various adverse events. We c...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of gastroenterology and hepatology

دوره 26 4  شماره 

صفحات  -

تاریخ انتشار 2011